Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with lymphoma (based on the WHO 2017 classification guidelines)
- People with a life expectancy of at least 3 months
- People willing to sign a written informed consent form to participate
Who may not be able to join:
- People who have a history of another type of cancer, or who currently have another active cancer that requires treatment
- People who the trial researchers have determined are not suitable to participate for any reason (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yanyan Liu, M.D. Ph.D, Henan Cancer Hospital
Phone: +8613818176375
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of driver gene abnormalities
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.